Prothrombotic factors enhance heparin‐induced thrombocytopenia and thrombosis in vivo in a mouse model
- 1 December 2006
- journal article
- Published by Elsevier BV in Journal of Thrombosis and Haemostasis
- Vol. 4 (12), 2687-2694
- https://doi.org/10.1111/j.1538-7836.2006.02201.x
Abstract
No abstract availableKeywords
This publication has 59 references indexed in Scilit:
- Predictors for the Development of Elevated Anti-Heparin/Platelet Factor 4 Antibody Titers in Patients Undergoing Cardiac CatheterizationThe American Journal of Cardiology, 2006
- Lipoprotein Retention—and Clues for Atheroma RegressionArteriosclerosis, Thrombosis, and Vascular Biology, 2005
- Circulating adhesion molecules in apoE-deficient mouse strains with different atherosclerosis susceptibilityBiochemical and Biophysical Research Communications, 2005
- Incidence of antiplatelet factor 4/heparin antibody induction in patients undergoing percutaneous coronary revascularizationThe American Journal of Cardiology, 2005
- The homozygous FcγRIIIa-158V genotype is a risk factor for heparin-induced thrombocytopenia in patients with antibodies to heparin-platelet factor 4 complexesBlood, 2004
- Pathogenicity of IgA and/or IgM antibodies to heparin–PF4 complexes in patients with heparin‐induced thrombocytopeniaBritish Journal of Haematology, 1996
- Immune Endothelial-Cell Injury in Heparin-Associated ThrombocytopeniaNew England Journal of Medicine, 1987
- The effect of hypercholesterolemia on guinea pig platelets, erythrocytes and megakaryocytesBiochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism, 1985
- Heparin-Associated ThrombocytopeniaNew England Journal of Medicine, 1980
- Effect of Cholesterol on Production of Thromboxane B2by Platelets in VitroNew England Journal of Medicine, 1980